ACAD
48.19
-0.62
-1.27%
AEMD
9.5
-0.49
-4.90%
APRI
1.38
-0.06
-4.17%
ARNA
4.06
+0.02
+0.50%
ATEC
1.36
0.00
0.00%
CNAT
4.49
-0.25
-5.27%
CRXM
0.3
0.00
0.00%
CYTX
0.427
-0.014
-3.0682%
DXCM
84.53
-0.12
-0.14%
GNMK
8.04
-0.46
-5.41%
HALO
23.03
-0.31
-1.33%
ILMN
216.7
-2.6
-1.19%
INNV
0.155
0.00
0.00%
INO
7.25
-0.04
-0.55%
ISCO
0.043
0.00
0.00%
ISIS
53.96
-0.97
-1.77%
LGND
108.74
+0.48
+0.44%
LPTN
0.264
-0.006
-2.1111%
MBVX
2.01
-0.15
-6.94%
MEIP
1.49
-0.07
-4.49%
MNOV
3.73
-0.02
-0.53%
MRTX
27.96
-0.65
-2.27%
MSTX
0.43
-0.017
-3.8014%
NBIX
48.99
-1.13
-2.25%
NUVA
55.19
+0.18
+0.33%
ONCS
5.98
-0.08
-1.32%
ONVO
3.35
-0.03
-0.89%
OREX
3.96
-0.04
-1.00%
OTIC
25.97
+0.2
+0.78%
QDEL
20.62
-0.09
-0.43%
RCPT
228.56
+0.7
+0.31%
RGLS
7.99
-0.21
-2.56%
RMD
55.4
-2.55
-4.40%
SCIE
0.018
0.00
0.00%
SPHS
0.844
-0.026
-2.944%
SRNE
21.17
+0.39
+1.88%
TROV
7.88
0.00
0.00%
VICL
0.628
-0.016
-2.484%
ZGNX
19.6
+0.29
+1.50%
ACAD
48.19
-0.62
-1.27%
AEMD
9.5
-0.49
-4.90%
APRI
1.38
-0.06
-4.17%
ARNA
4.06
+0.02
+0.50%
ATEC
1.36
0.00
0.00%
CNAT
4.49
-0.25
-5.27%
CRXM
0.3
0.00
0.00%
CYTX
0.427
-0.014
-3.0682%
DXCM
84.53
-0.12
-0.14%
GNMK
8.04
-0.46
-5.41%
HALO
23.03
-0.31
-1.33%
ILMN
216.7
-2.6
-1.19%
INNV
0.155
0.00
0.00%
INO
7.25
-0.04
-0.55%
ISCO
0.043
0.00
0.00%
ISIS
53.96
-0.97
-1.77%
LGND
108.74
+0.48
+0.44%
LPTN
0.264
-0.006
-2.1111%
MBVX
2.01
-0.15
-6.94%
MEIP
1.49
-0.07
-4.49%
MNOV
3.73
-0.02
-0.53%
MRTX
27.96
-0.65
-2.27%
MSTX
0.43
-0.017
-3.8014%
NBIX
48.99
-1.13
-2.25%
NUVA
55.19
+0.18
+0.33%
ONCS
5.98
-0.08
-1.32%
ONVO
3.35
-0.03
-0.89%
OREX
3.96
-0.04
-1.00%
OTIC
25.97
+0.2
+0.78%
QDEL
20.62
-0.09
-0.43%
RCPT
228.56
+0.7
+0.31%
RGLS
7.99
-0.21
-2.56%
RMD
55.4
-2.55
-4.40%
SCIE
0.018
0.00
0.00%
SPHS
0.844
-0.026
-2.944%
SRNE
21.17
+0.39
+1.88%
TROV
7.88
0.00
0.00%
VICL
0.628
-0.016
-2.484%
ZGNX
19.6
+0.29
+1.50%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …